LONDON--(BUSINESS WIRE)--   FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Verition Fund Management LLC (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee...

LONDON--(BUSINESS WIRE)--   FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Verition Fund Management LLC (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee...

Rani Therapeutics Holdings, Inc. ( RANI ) stock surged Friday after unveiling two major announcements: a licensing collaboration with Chugai Pharmaceutical Co., Ltd., and a $60.3 million private placement financing led by Samsara BioCapital. The twin developments mark a significant boost to the clinical-stage biotherapeutics firm’s funding and strategic partnerships. Under the newly signed collaboration and license agreement, Rani will...

09:46 AM EDT, 10/17/2025 (MT Newswires) -- Kinaxis ( KXSCF ) Friday announced Maestro Agents, an AI-enabled decision intelligence for supply chains. The company said these AI-powered context aware digital co-workers help planners move faster from issue to action, turning disruption into opportunity, and strengthening the resilience of the supply chains that power the global economy. Kinaxis ( KXSCF )...